Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers February 10, 2016
Pharmacy Choice - Pharmacy News - February 10, 2016

Pharmacy News

Today's Pharmaceutical and Pharmacy News
Daily News Topic:

FDA News
2/10/16 - Avanir Pharmaceuticals Announces FDA Approval of ONZETRA Xsail AVP-825 for the Acute Treatment of Migraine in Adults
By a News Reporter-Staff News Editor at Biotech Week-- Avanir Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved ONZETRAâ?¢ Xsailâ?¢, formerly known as AVP-825, for the acute treatment of migraine with or without aura in adults. Given this high dissatisfaction, there remains an unmet need to provide patients wit
2/10/16 - FDA approves Adaptimmune Therapeutics 'breakthrough' cancer treatment [The Philadelphia Inquirer]
Feb. 10-- Adaptimmune Therapeutics, a biopharmaceutical company with U.S. operations in Philadelphia, said Tuesdaythe Food and Drug Administration has granted "breakthrough therapy designation" for its TCR engineered T-cell therapy to treat cancer. Adaptimmune, which has a collaboration and licensing agreement with GlaxoSmithKline to commercialize
2/10/16 - FDA Grants Priority Review to KemPharm for KP201/APAP NDA
--KemPharm, Inc. today announced that the New Drug Application for KP201/APAP, its investigational drug candidate for the short-term management of acute pain, has been accepted and granted priority review by the U.S. Food and Drug Administration. â??We believe this milestone brings us one step closer to providing prescribers and patients with a new
2/10/16 - OptiNose Announces FDA Approval for ONZETRAâ?¢ Xsailâ?¢ sumatriptan nasal powder, a New Treatment for Acute Migraine Using Bi-Directionalâ?¢ Breath...
By a News Reporter-Staff News Editor at Biotech Week-- OptiNose, a privately-held specialty biopharmaceutical company, announced that its licensing partner, Avanir Pharmaceuticals, Inc. has reported that the U.S. Food& Drug Administration approved ONZETRAâ?¢ Xsailâ?¢, formerly AVP-825, for the acute treatment of migraine with or without aura in adu
2/10/16 - Seattle Genetics Reports Fourth Quarter and Year 2015 Financial Results [Global Data Point]
For ADCETRIS, we achieved record sales in the fourth quarter and for the year, received FDA approval for an expanded label, completed enrollment in two of three ongoing phase 3 trials and continued our efforts to establish ADCETRIS as the foundation of care for CD30-expressing lymphomas, "said Clay Siegall, Ph.D., President and Chief Executive Offi
2/9/16 - 3 parent embryos approved
The committee, which was convened last year at the request of the US Food and Drug Administration, concluded it is ethically permissible toâ?? go forward, but with cautionâ?? with mitochondrial replacement techniques, said chairman Jeffrey Kahn, a bioethicist at Johns Hopkins University. But the advisory panelâ?? s conclusions have slammed into a c

Chain Drug Review
Chain Drug Review Magazine Chain Drug Review, established in 1978 and published 21 times a year, is recognized as the premier news publication serving the entire chain drug store industry.
Featured Article from Chain Drug Review:
AWP suit settlement appealed
The National Association of Chain Drug Stores has appealed a U.S. District Court’s approval of settlements in the First DataBank Inc. and Medi-Span Inc. lawsuit. »read more

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement